chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patients entire arm was in pain, with numbness and tingling down the arm. Painful to touch or move and keeping the patient up at night. Patient is taking OTC pain relievers, which are not helping. Patient is going to see a doctor today. This is in right arm only.
Pain at the injection site (more so than the first two shots in the series), nausea daily since shot was administered and pain in her side.
After receiving the Pfizer vaccine, the patient was vomiting and placed on her side. She also had a seizure about 20 minutes after receiving the vaccine the vaccine.
no adverse effect reported; expired PNEUMOVAX 23 was administered; This spontaneous report was received from a nurse refers to a patient of unknown age and gender. The patient's concurrent condition, concomitant medication and medical history were unknown. On 23-SEP-2019, the patient was vaccinated with expired pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) injection (lot # N024385 with expiry date 18-MAY-2019, intramuscular; dose number and frequency unspecified) for prophylaxis (expired product administered). No adverse effects reported (no adverse event). The outcome of the events was unknown. No product quality complaint was involved.
Information has been received from a physician concerning a female who was intramuscularly, vaccinated with the second dose of HPV vaccine. Subsequently the patient developed an anaphylactic reaction (swelling of the throat, itching of hands and feet). At the time of the report, it was not reported if the patient recovered. The physician determined that the patient's anaphylactic reaction (Swelling of the throat, itching of hands and feet) was considered to be immediately life threatening, disabling and an other important medical event. Additional information has been requested.
Patient received two flu shots previous season (2022-2023 season). Received 2023 flu shot on 10/4/23. Erroneously received a second flu shot this season on 10/28/23. No adverse effects reported.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Whole left arm hurt really bad), OROPHARYNGEAL PAIN (Slight sore throat), CONTUSION (Bruised area of hip and pain in right hip), MYALGIA (muscle spasms and arm pain) and PYREXIA (fever of 99-100 degrees) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 26-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (Whole left arm hurt really bad), OROPHARYNGEAL PAIN (Slight sore throat), CONTUSION (Bruised area of hip and pain in right hip), MYALGIA (muscle spasms and arm pain), PYREXIA (fever of 99-100 degrees) and ARTHRALGIA (Bruised area of hip and pain in right hip). At the time of the report, PAIN IN EXTREMITY (Whole left arm hurt really bad), OROPHARYNGEAL PAIN (Slight sore throat), CONTUSION (Bruised area of hip and pain in right hip), MYALGIA (muscle spasms and arm pain), PYREXIA (fever of 99-100 degrees) and ARTHRALGIA (Bruised area of hip and pain in right hip) outcome was unknown.
1st dose 2-3 years ago; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 68-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received 2-3 years ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable to this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. No reactions reported. The reporter consented to follow-up via email.
At exact time of infection,  whole left arm started getting tingly and warm,  especially from crook of elbow down through fingers. My usual comfortable watch felt tight and annoying.   Was able to walk to observation area,  then started getting dizzy and light- headed.  Still had warm,  tingly feeling in arm that received injection.  My normal resting heart rate is 61 but now it was up to 111 per smart watch (possibly 121 but can't confirm since I was dizzy and blurry-eyed). In addition to tingly arm,  racing heart,  dizziness,  I felt immediate fatigue and wanted to lay down and sleep. Also,  had dull headache on left-side.  Nurse sat me down and elevated my feet. Also got me some frozen peas for my forehead and neck.  After 12-13 mintues,  I started feeling better.  She kept me under observation for full hour.  Got better and went home.  Heart rate remained elevated at 78-89 rest of evening.  Dull headache remained on left- side only. Similar feeling to when wearing a tight pony tail and you take it out.
On 8/5/04, he was taken to health dept for catch up immunizations. His parents did not bring his prior shot record. Five immunizations were givne. He develoed fever startin on 8/6/04 and lasted for 4-5 days. On 8/12, he began to complain of the knee pains with arthritis and swelling, it migrated to left knee on the next two days. Several visits to ER were made. He then progressed to develop typical findings of Henoch-Scholein purpura around 9/1/04 and resolved after PO steroids.
Sudden onset diarrhea followed within a few minutes by body aches that became severe within 1 hour. Severe chills and sweating that lasted into the early morning hours. I awoke around 3 AM soaked with sweat and still with chills. I got up at around 8 AM and felt much better.  Still having periodic diarrhea that is not explained by my diet.
At approximately 6:00PM Tuesday May 4 (approx 8 hours after second dose): Fever up to 101.6 F, severe chills, muscle pain at injection site, profuse vomiting ( at least 7 times between 10:00PM and 4:00AM 05/05), muscle spasms in upper legs. Severe stutter  On Wednesday May 5, starting around 3:00PM: Persistent stutter, full body jitters that progressed to upper body muscle spasms (primarily in the neck and shoulder region) that worsened throughout the evening. Checked into the ER approximately 4:30PM and was administered a muscle relaxant (I believe) through an IV to lessen the spasms around 7:00PM. Muscle spasms and stutter persisted until approximately 4:00PM on Thursday, May 6 at time of discharge from hospital.
This spontaneous report as received from a nurse, refers to unspecified number of patients of unknown demography. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patients were vaccinated with improperly stored ZOSTAVAX injection (strength, dose, route and lot number or batch number unspecified). No concomitant medications were reported. No symptoms were reported. The outcome of the event was unknown. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
Nosebleed; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old adult male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 25Mar2021 at 14:30 (at the age of 40-years-olds), as a single dose for COVID-19 immunisation. Medical history was not reported. Other medications received within two weeks of vaccination reported as not applicable (NA). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 25Mar2021 at 18:00, the patient experienced nosebleed. The patient did not receive any treatment for the event nosebleed. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of event nosebleed was resolving at the time of this report.   No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Starting yesterday around 4:30-5:00pm I realized my arm hurt way worse than the first shot, by 7:30 pm I couldn?t stretch my arm above my head. At that point a severe headache and body aches began and would only get worse through the night, when I finally fell asleep I was freezing and weak, coughed a bit. I woke up around 5:30am full body sweating, I only took some aleeve cold and sinus last night and this morning.  This morning around 11:00am the side effects lessened greatly.
Swelling, redness in right arm at injection site at 2:00am Friday 10/03/08.  Patient iced site and swelling resolved.  Later in evening 10/03/08 swelled again and took BENADRYL and condition resolved.
Severe headaches exhaustion depression, crying spells, mental breakdown severe muscle spasms over the neck, upper, middle, and lower back Knee pain
After 8 days the injection site is still swollen and hot to the touch. It's also itchy. Usually, those types of symptoms last a couple of days.
Information has been received from a health professional concerning his 62 year old wife with allergies to minocycline, erythromycin and Keflex who on 01-JUN-2007 was vaccinated with Zostavax (Oka/Merck).  Concomitant therapy included an unspecified over the counter antacid.  On 02-JUN-2007 the patient experienced a moderate to severe injection site reaction.  The area affected was 6 to 7 inches long and 4 to 5 inches wide.  It was oval shaped and had progressed toward the elbow.  It was pale pink and indurated.  At the upper end of the oval there was a dark red circle that was approximately 3cm in diameter.  The reporter noted that the entire injection site area looked like a distorted bulls eye.  the patient has mild to moderate pain in the area.  The patient was afebrile and taking Aleve for the reaction.  There were no labs performed.  The patient tried to call her physician but they were unavailable.  As of 04-JUN-2007, she had not recovered.  Additional information has been requested. This is in follow-up to previously submitted on 9/24/2007. Information has been received from a physician concerning a 62 year old female with allergic reaction to minocycline, erythromycin, and KELFEX, colonic polyp, rhinitis allergic, obstructive sleep apnoea syndrome, glaucoma, lipids increased. DEMEROL allergy who on 01-JUN-2007 was vaccinated SC with Zostavax (Merck) (lot #657559/0462U). Concomitant therapy included an unspecified over the counter antacid. On 03-JUN-2007 the patient experienced a moderate to severe injection site reaction. The area affected was a 10-15 cm patch. It was oval shaped and had progressed toward the elbow. It was pruritic, pale pink and indurated. At the upper end of the oval there was a dark red circle that was approximately 3cm in diameter. The reporter noted that the entire injection site area looked like a distorted bulls eye. The patient had mild to moderate pain in the area. The patient was afebrile and taking Aleve for the reaction. There were no labs performed. The patient tried to call her physicians but they were unavailabe. As of 05-JUN-2007. She had not recovered. Additional information is not expected.
This case was reported by a nurse and described the occurrence of injection site induration in a 16-year-old female patient who received MENVEO (batch number X15099, expiry date unknown). On 9th June 2016, the patient received MENVEO. On an unknown date, less than a year after receiving MENVEO, the patient experienced injection site induration and injection site redness. On an unknown date, the outcome of the injection site induration and injection site redness were recovered/resolved. It was unknown if the reporter considered the injection site induration and injection site redness to be related to MENVEO. Additional details were provided as follows: In the morning of reporting date, the sales representative called the office nurse and at this visit they discussed that there were a high number of patients with severe local reactions to the MENVEO and BEXSERO vaccines. These patients were returning to their office with very large, reddened, swollen, hardened, warm induration at the injection site and the surrounding area, many times measuring 6 inches or more from the injection site. The physician had prescribed oral antibiotics for most of these patients. The patient concerned in this case had experienced 5 to 7 mm induration and redness at injection site after vaccination with booster dose of MENVEO, which had lasted for 5 days. She was monitored for the events. The reporter had tried several different methods of mixing the vaccine (letting it sit, administering it immediately, etc) but none had provided effective in reducing reaction rates. The reporter requested for suggestions on how they could possibly reduce the potential for a local reactions. Also, they inquired if there had been any problems with certain lot numbers of the vaccine, so that they could compare those numbers to the vaccines which they administered to their patients. This case has been linked to 4 other cases (MENVEO vaccine), reported by the same reporter.
One hour prior to receiving this MMR, client received her #2 dose of adult Hep-B vaccine at doctor's office. She denies any reaction to her 1st dose of Hep-B vaccine, which was given one month prior to this 2nd dose. She then came to HD for her 1st dose of MMR vaccine, as doctor's office out of vaccine. Chest pain and SOB evening of 6/11/06. Petechial rash began on both arms 6-12 and has continued to spread quickly to entire body as of report date. Older portions of rash have faded, but seem to have consolidated into clusters. Fever of 102F evening of 6/13/06, 101F on 6/14 and 100F on 6/15. As of this report date, 6/16, her fever has resolved without further episodes. Seen by NP at doctor's office on 6/14/06. At that time she presented with fever, spreading rash and SOB with tachycardia. Was sent to ER for evaluation and treatment, as indicated. Was discharged home after receiving IV ibuprofen. Per pt, no other meds or prescriptions were given. She reports a history of intermittent tachycardia over the past 4 years, and intermittent SOB over the past 20 years. As of today, 6/16/06, pt is fever free, but head to toe rash has not yet resolved.
Pt received vaccine at 09:52. 10:22 pt started to itching on arms and back. No visible rash. No chest pain, stridor, sob, tongue or lip swelling.  Hx of allergies to pcn, iodine, sulfa, latex. Hx of rash and itching with pneumonia shot. No hx of anaphalxis to vaccines or meds - just itching and rash.  VSS . 98 % RA 68.  BP 177/84 (pt did not take her BP medication as of this mornig). Pt states she feels well but still itching as of 10:41. Pt appears to have the ability to make her own decisions and would like to talk to husband about going to ER. If pt still itching, recommend pt be evaluated. Pt would like d/w husband and physician prior to going to ER. EMS crew on standby.   Note from ED: This is a well-appearing and pleasant 72-year-old female who presented via ambulance for itching response after receiving the Pfizer COVID-19 vaccine today. Patient is very well-appearing. Skin is normal and well-appearing there is no rash or erythema. Patient is speaking in complete sentences with normal work of breathing. Respirations are even and nonlabored. Lung fields are clear to auscultation bilaterally throughout patient denies any shortness of breath or breathing issues, cough or itchy throat. Airway is clear with no tongue or mouth swelling, floor mouth is soft and not elevated mandible is easily palpated, throat is nontender, neck is supple. Heart rate is within normal limits with regular rhythm. She was provided with Benadryl and famotidine as treatment for her itching. Patient was observed for greater than 2-1/2 hours in the emergency department. Patient noted that itching markedly reduced with use of Benadryl I felt patient was appropriate and stable for discharge. I had an in-depth discussion with her regarding she monitor her symptoms closely at home we discussed all symptoms that she should look for that would be concerning and she should make sure to seek emergent care. She was given the opportunity ask questions. All question concerns were thoroughly addressed. Patient indicated she felt good with her care here today with discharge and would monitor herself at home. She was picked up by her husband would also be home to monitor her. Advised her to follow-up with her primary care provider regarding recommendations for whether she should receive her second dose of the vaccine. Provided her with CDC printed out recommendations for vaccine allergic reaction. She was given the opportunity ask questions. All questions and concerns were addressed and answered to the best of my ability. No evidence of Stevens-Johnson syndrome, anaphylaxis, cellulitis, or systemic compromise Feel supportive care and symptomatic treatment reasonable. Urged dermatologic follow up. At time of discharge patient remained well-appearing not in any type of acute distress. She ambulated out of the emergency department with a steady gait. I reviewed recent and relevant Chart Entries, Previous Notes, Previous Labs, Previous Radiology studies.
Initial report received from a health care professional (nurse) on 24 Aug 2010: This child was vaccinated with MENVEO (batch number: 100022), 0.5 ml intramuscularly on 18 Aug 2010. On 19 Aug 2010, the child experienced injections site reactions, consistent with swelling, redness and pain. On 20 Aug 2010, the child was treated in the emergency room as the symptoms had worsened. The outcome of the event was reported as condition improving.
Pt c/o headaches, fatigue and pain in L upper arm later radiating to L neck area. Symptoms started on day 7 and lasted x 2 days. Pt given 24 hrs quarters to rest, given Toradol 60mg IM.
No Adverse event; Recieved 0.5 ml of bivalent booster instead of primary series; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Recieved 0.5 ml of bivalent booster instead of primary series) and NO ADVERSE EVENT (No Adverse event) in a 27-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On 06-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 06-Oct-2022, the patient experienced WRONG PRODUCT ADMINISTERED (Recieved 0.5 ml of bivalent booster instead of primary series). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Recieved 0.5 ml of bivalent booster instead of primary series) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Recieved 0.5 ml of bivalent booster instead of primary series).    No concomitant medications were provided.  The patient did not have a history of COVID 19 vaccination. .  No treatment medication was provided.
This case was reported by a consumer via call center representative and described the occurrence of swelling arm in a female patient who received SHINGRIX. In March 2018, the patient received the 1st dose of SHINGRIX. In March 2018, less than a week after receiving SHINGRIX, the patient experienced swelling arm and erythema of extremities. On an unknown date, the outcome of the swelling arm and erythema of extremities were not recovered/not resolved. It was unknown if the reporter considered the swelling arm and erythema of extremities to be related to SHINGRIX. Additional were provided as follows: The age at vaccination was not reported. The patient had 1st SHINGRIX shot 7 days ago and her arm was still slightly red and swollen. The reporter wanted to know if there was something that could be done to get the swelling down.
arm very sore; her son received 6 times the amount of the vaccine dosage/overdosed 6 times the normal amount/over dosed him on the amount by 6 times, a huge mistake; This is a spontaneous report from a contactable consumer company CEP 2191. A 26-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot/Batch number: Unknown) on 04Feb2021 via an unspecified route of administration in the arm at SINGLE DOSE for COVID-19 Immunization. The patient's medical history and concomitant medications were not reported. The reporter stated her son received 6 times the amount of the vaccine dosage. The patient had not administered pfizer vaccine on same date and not had prior vaccinations (within 4 weeks prior to the first administration date of the suspect vaccine. The patient had no AE's prior vaccinations. The patient had no any illness at time of vaccination and was not diagnosed with allergies, compromised immune status, respiratory illness, genetic /chromosomal abnormalities, endocrine abnormalities (including diabetes) and obesity. The patient experienced her son received 6 times the amount of the vaccine dosage/overdosed 6 times the normal amount/overdosed him on the amount by 6 times, a huge mistake on 04Feb2021 and arm very sore on an unspecified date. The patient was concerned about side effects. The patient has been feeling fine and has not mentioned any issues since the overdose. The patient had no relevant test and no had any illness. The outcome of the events was not recovered.   This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Pt was given an expired Pfizer vaccine for second dose. Vaccine expired on 8/30/21 at 9:59pm, vaccine was given on 8/31/2021 at 9:35am. Pt was stable and was monitored for over 45 min in the clinic, no adverse reaction noted. Dr was notified as well.
took vax next AM began itching behind ears & along hairline-the next 3-4 days began itching on chest & back;
Narrative:  Patient received a zoster vaccine on 8/20/21 and 7 days later he reported right upper extremity swelling. He was later diagnosed with gout in the right hand which was believed to have caused his right hand swelling. He received 1.2 mg colcichine and 5 days of indomethacin 50 mg.